Photo de couverture de Delpharm
Delpharm

Delpharm

Fabrication de produits pharmaceutiques

A worldwide leader in contract development and manufacturing of medicines

À propos

Delpharm is a worldwide leader in contract manufacturing and development of medicines with : - 19 plants in France, Italy, Canada, Poland and The Netherlands - Over 1,1 billion euros turnover - Over 6,500 people - 6,500 people working in the company - Most dosage forms produced For over 35 years, Delpharm has grown by progressively acquiring production plants, notably from major pharmaceutical laboratories. Today, Delpharm operates 18 industrial sites and 3 development centers located in France, Italy, Canada, the Netherlands, and Poland, producing over one billion boxes of medicines per year and contributing to the development of numerous projects. As multi-specialists, Delpharm is able to supply the majority of pharmaceutical forms available on the market, such as tablets and capsules, bottles and injectable ampoules, prefilled syringes, freeze-drying, suspensions, solutions, ointments and soft gel capsules. Delpharm also offers full development services for a wide range of pharmaceutical forms, chemical entities and innovative combinations, including the production of phase 1 to 3 clinical batches for solid, semi-solid, liquid and injectable forms.

Site web
http://www.delpharm.com/en/
Secteur
Fabrication de produits pharmaceutiques
Taille de l’entreprise
5 001-10 000 employés
Siège social
Boulogne-Billancourt
Type
Société civile/Société commerciale/Autres types de sociétés
Domaines
CMO, PHARMACEUTICAL DRUG, SOLID FORM, LIQUID FORM, SEMI SOLID FORM, CDMO, HORMONE, ONCOLOGY, STERILE, SERIALIZATIUON, SERIALISATION, FABRICATION MEDICAMENT, FDA, PMDA, ANVISA, DRUG MANUFACTURING, DRUG PLANT, DRUG DEVELOPMENT, SOFTGEL et REGULATORY

Lieux

Employés chez Delpharm

Nouvelles

  • Voir la Page de l’organisation de Delpharm

    73 207  abonnés

    𝐌𝐞𝐞𝐭 𝐒𝐞́𝐯𝐞𝐫𝐢𝐧𝐞, 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐲 𝐓𝐞𝐜𝐡𝐧𝐢𝐜𝐢𝐚𝐧 𝐚𝐭 𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦. 📽️ In this interview, Séverine talks about her career path and her job at Delpharm Would you like to learn more about careers and opportunities in our industry? 👉 Visit our website https://lnkd.in/d93a_xw #Delpharm #personalbranding #carreers

  • Voir la Page de l’organisation de Delpharm

    73 207  abonnés

    𝐌𝐞𝐞𝐭 𝐂𝐡𝐢𝐚𝐫𝐚 𝐂𝐚𝐫𝐛𝐨𝐧𝐢, 𝐒𝐢𝐭𝐞 𝐃𝐢𝐫𝐞𝐜𝐭𝐨𝐫 - 𝐃𝐄𝐋𝐏𝐇𝐀𝐑𝐌 𝐃𝐄𝐕𝐄𝐋𝐎𝐏𝐌𝐄𝐍𝐓 𝐋𝐄𝐈𝐃𝐄𝐍, 𝐚𝐭 𝐂𝐏𝐡𝐈 𝐌𝐢𝐥𝐚𝐧 𝟐𝟎𝟐𝟔 "Can you handle the complexity of our injectable?" It's one of the first questions customers ask her. At Delpharm, precision, expertise and adaptability are exactly what we're built for. Our experts are here to answer your challenges with advanced technologies combined and a wide range of product expertise. Chiara will be at CPhI Worldwide Milan, October 6-8, and would genuinely enjoy talking through your sterile development challenges. 📍 Come say hello at 𝐛𝐨𝐨𝐭𝐡 𝟔𝐇𝟏𝟐. Let's talk sterile. #CPhI2026 #Delpharm #SterileManufacturing #CDMO

    • Aucune description alternative pour cette image
  • Voir la Page de l’organisation de Delpharm

    73 207  abonnés

    𝐂𝐀𝐒𝐄 𝐒𝐓𝐔𝐃𝐘 - 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐢𝐭𝐲 𝐨𝐟 𝐂𝐚𝐫𝐞 𝐔𝐧𝐝𝐞𝐫 𝐄𝐱𝐭𝐫𝐞𝐦𝐞 𝐂𝐢𝐫𝐜𝐮𝐦𝐬𝐭𝐚𝐧𝐜𝐞𝐬 𝐏𝐨𝐬𝐭 𝟑/𝟑 — 𝐓𝐡𝐞 𝐑𝐞𝐬𝐮𝐥𝐭𝐬 𝐙𝐞𝐫𝐨 𝐦𝐚𝐫𝐤𝐞𝐭 𝐝𝐢𝐬𝐫𝐮𝐩𝐭𝐢𝐨𝐧. 𝐓𝐡𝐚𝐭 𝐰𝐚𝐬 𝐭𝐡𝐞 𝐭𝐚𝐫𝐠𝐞𝐭 - 𝐚𝐧𝐝 𝐭𝐡𝐚𝐭'𝐬 𝐞𝐱𝐚𝐜𝐭𝐥𝐲 𝐰𝐡𝐚𝐭 𝐰𝐚𝐬 𝐝𝐞𝐥𝐢𝐯𝐞𝐫𝐞𝐝. 𝑄𝑢𝑖𝑐𝑘 𝑟𝑒𝑐𝑎𝑝: 𝑎 𝑐𝑙𝑖𝑒𝑛𝑡 𝑓𝑎𝑐𝑒𝑑 𝑎𝑛 18-𝑚𝑜𝑛𝑡ℎ 𝑑𝑒𝑎𝑑𝑙𝑖𝑛𝑒 𝑡𝑜 𝑡𝑟𝑎𝑛𝑠𝑓𝑒𝑟 𝑎 𝑐𝑟𝑖𝑡𝑖𝑐𝑎𝑙 𝑚𝑒𝑑𝑖𝑐𝑖𝑛𝑒 𝑤𝑖𝑡ℎ 𝑎𝑙𝑚𝑜𝑠𝑡 𝑛𝑜 𝑝𝑟𝑜𝑐𝑒𝑠𝑠 𝑘𝑛𝑜𝑤𝑙𝑒𝑑𝑔𝑒 𝑎𝑛𝑑 𝑛𝑜 𝑟𝑜𝑜𝑚 𝑓𝑜𝑟 𝑒𝑟𝑟𝑜𝑟. 𝐻𝑒𝑟𝑒'𝑠 𝑤ℎ𝑎𝑡 𝑡ℎ𝑒 𝑟𝑒𝑐𝑜𝑛𝑠𝑡𝑟𝑢𝑐𝑡𝑖𝑜𝑛 𝑎𝑛𝑑 𝑟𝑒𝑣𝑎𝑙𝑖𝑑𝑎𝑡𝑖𝑜𝑛 𝑑𝑒𝑙𝑖𝑣𝑒𝑟𝑒𝑑. The outcome:  ✅Continuity of care for patients - a public health issue fully resolved   ✅ Full industrial transfer completed in record time   ✅ A process that's now robust, well-managed, and optimised   ✅ Significant gains in industrial efficiency   ✅ A stronger, closer client relationship built on proactive collaboration 𝐖𝐡𝐚𝐭 𝐦𝐚𝐝𝐞 𝐭𝐡𝐞 𝐝𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐜𝐞? ✅Deep technical expertise across formulation, aseptic processes, and analytical testing  ✅The ability to rebuild critical knowledge without a full transfer of documentation  ✅Speed and reliability under real time pressure  ✅Close collaboration with the client at every stage  ✅Anticipating regulatory challenges before they became blockers If you're facing a challenge of this magnitude, we're here to talk. https://lnkd.in/dwn_qsp 📄 Read the full technical case study - including methodology, validation data, and transferable lessons - on our website. If you're evaluating a similar transfer, this is worth the deeper read.  https://lnkd.in/eA9_WNjH  #SupplyChainResilience #PharmaManufacturing #CDMO #PatientSafety #Delpharm 

    • Aucune description alternative pour cette image
  • Voir la Page de l’organisation de Delpharm

    73 207  abonnés

    𝐌𝐞𝐞𝐭 Nicolas Leforestier, 𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦’𝐬 𝐂𝐡𝐢𝐞𝐟 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐎𝐟𝐟𝐢𝐜𝐞𝐫, 𝐚𝐭 𝐂𝐏𝐡𝐈 𝐌𝐢𝐥𝐚𝐧 𝟐𝟎𝟐𝟔 18 manufacturing sites. 1.1 million units produced every year. Behind every one of those numbers is a promise we make to our customers: your product, delivered on time, at scale, without compromise. That's what industrial excellence means to Delpharm — not just capacity, but reliability you can build a launch plan around. At CPhI Worldwide Milan, Nicolas will be sharing how our network of sites gives you the flexibility to scale — from early phase to full commercial volumes — without losing speed or quality. 📍 𝐌𝐞𝐞𝐭 𝐮𝐬 𝐚𝐭 𝐛𝐨𝐨𝐭𝐡 𝟔𝐇𝟏𝟐, 𝐎𝐜𝐭𝐨𝐛𝐞𝐫 𝟔-𝟖. Let's talk about what industrial excellence looks like for your project. #CPhI2026 #Delpharm #CDMO #Manufacturing

    • Aucune description alternative pour cette image
  • Voir la Page de l’organisation de Delpharm

    73 207  abonnés

    𝐂𝐀𝐒𝐄 𝐒𝐓𝐔𝐃𝐘 - 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐢𝐭𝐲 𝐨𝐟 𝐂𝐚𝐫𝐞 𝐔𝐧𝐝𝐞𝐫 𝐄𝐱𝐭𝐫𝐞𝐦𝐞 𝐂𝐢𝐫𝐜𝐮𝐦𝐬𝐭𝐚𝐧𝐜𝐞𝐬 𝐏𝐨𝐬𝐭 𝟐/𝟑 - 𝐓𝐡𝐞 𝐀𝐩𝐩𝐫𝐨𝐚𝐜𝐡 𝐖𝐡𝐞𝐧 𝐭𝐡𝐞 𝐩𝐞𝐨𝐩𝐥𝐞 𝐰𝐡𝐨 𝐤𝐧𝐞𝐰 𝐭𝐡𝐞 𝐩𝐫𝐨𝐜𝐞𝐬𝐬 𝐚𝐫𝐞 𝐠𝐨𝐧𝐞, 𝐲𝐨𝐮 𝐝𝐨𝐧'𝐭 𝐠𝐮𝐞𝐬𝐬. 𝐘𝐨𝐮 𝐫𝐞𝐛𝐮𝐢𝐥𝐝 𝐭𝐡𝐞 𝐤𝐧𝐨𝐰𝐥𝐞𝐝𝐠𝐞 𝐟𝐫𝐨𝐦 𝐟𝐢𝐫𝐬𝐭 𝐩𝐫𝐢𝐧𝐜𝐢𝐩𝐥𝐞𝐬. 𝘘𝘶𝘪𝘤𝘬 𝘳𝘦𝘤𝘢𝘱: 𝘢 𝘤𝘭𝘪𝘦𝘯𝘵'𝘴 𝘭𝘰𝘯𝘨-𝘴𝘵𝘢𝘯𝘥𝘪𝘯𝘨 𝘮𝘢𝘯𝘶𝘧𝘢𝘤𝘵𝘶𝘳𝘦𝘳 𝘴𝘩𝘶𝘵 𝘥𝘰𝘸𝘯, 𝘭𝘦𝘢𝘷𝘪𝘯𝘨 18 𝘮𝘰𝘯𝘵𝘩𝘴 𝘵𝘰 𝘵𝘳𝘢𝘯𝘴𝘧𝘦𝘳 𝘢 𝘴𝘦𝘯𝘴𝘪𝘵𝘪𝘷𝘦 𝘢𝘴𝘦𝘱𝘵𝘪𝘤 𝘮𝘦𝘥𝘪𝘤𝘪𝘯𝘦 𝘸𝘪𝘵𝘩 𝘢𝘭𝘮𝘰𝘴𝘵 𝘯𝘰 𝘥𝘰𝘤𝘶𝘮𝘦𝘯𝘵𝘦𝘥 𝘱𝘳𝘰𝘤𝘦𝘴𝘴 𝘬𝘯𝘰𝘸𝘭𝘦𝘥𝘨𝘦. 𝘏𝘦𝘳𝘦'𝘴 𝘩𝘰𝘸 𝘸𝘦 𝘵𝘢𝘤𝘬𝘭𝘦𝘥 𝘪𝘵. Here's how our teams tackled it:  - 𝐑𝐞𝐜𝐨𝐧𝐬𝐭𝐫𝐮𝐜𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 𝐩𝐫𝐨𝐜𝐞𝐬𝐬   - 𝐏𝐫𝐨𝐜𝐞𝐬𝐬 𝐨𝐩𝐭𝐢𝐦𝐢𝐬𝐚𝐭𝐢𝐨𝐧   - 𝐐𝐮𝐚𝐥𝐢𝐭𝐲 𝐚𝐬𝐬𝐮𝐫𝐚𝐧𝐜𝐞   - 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐢𝐚𝐥 𝐚𝐝𝐚𝐩𝐭𝐚𝐭𝐢𝐨𝐧  Every step was designed around one constraint: the product had to keep reaching patients, without compromise. Next up: the results. [Follow for part 3] 📄 Want the full technical breakdown - including the Aseptic Process Simulation strategy and packaging redesign? Read the complete case study on our website  https://lnkd.in/eA9_WNjH #ProcessOptimisation #AsepticManufacturing #QualityAssurance #CDMO #Delpharm

    • Aucune description alternative pour cette image
  • Voir la Page de l’organisation de Delpharm

    73 207  abonnés

    𝐌𝐞𝐞𝐭 Nicolas Ragot, 𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦’𝐬 𝐂𝐄𝐎, 𝐚𝐭 𝐂𝐏𝐡𝐈 𝐌𝐢𝐥𝐚𝐧 𝟐𝟎𝟐𝟔 The pharma industry is changing faster than ever. At Delpharm, we're building for it — investing in demanding technologies and helping our partners move faster from molecule to patient. Nicolas will be at 𝐂𝐏𝐡𝐈 𝐖𝐨𝐫𝐥𝐝𝐰𝐢𝐝𝐞 𝐌𝐢𝐥𝐚𝐧, 𝐎𝐜𝐭𝐨𝐛𝐞𝐫 𝟔-𝟖, and would love to talk about where you see the industry heading — and how we can help you get there. 📍 Come find us at booth 6H12. #CPhI2026 #Delpharm #CDMO

    • Aucune description alternative pour cette image
  • Voir la Page de l’organisation de Delpharm

    73 207  abonnés

    📢 𝐖𝐞 𝐚𝐫𝐞 𝐩𝐥𝐞𝐚𝐬𝐞𝐝 𝐭𝐨 𝐰𝐞𝐥𝐜𝐨𝐦𝐞 Bruno Delie 𝐚𝐬 𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦'𝐬 𝐧𝐞𝐰 𝐂𝐡𝐢𝐞𝐟 𝐂𝐨𝐦𝐦𝐞𝐫𝐜𝐢𝐚𝐥 𝐎𝐟𝐟𝐢𝐜𝐞𝐫. With extensive international experience across the pharmaceutical industry in commercial, business development and strategic leadership roles, Bruno brings a deep understanding of the challenges our customers face throughout their journey. His expertise, combined with a strong partnership mindset, will help us continue delivering tailored solutions and supporting our customers' ambitions with agility, reliability and commitment. Welcome to Delpharm, Bruno! #Delpharm #CDMO #Leadership

    • Aucune description alternative pour cette image
  • Voir la Page de l’organisation de Delpharm

    73 207  abonnés

    𝐂𝐀𝐒𝐄 𝐒𝐓𝐔𝐃𝐘 - 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐢𝐭𝐲 𝐨𝐟 𝐂𝐚𝐫𝐞 𝐔𝐧𝐝𝐞𝐫 𝐄𝐱𝐭𝐫𝐞𝐦𝐞 𝐂𝐢𝐫𝐜𝐮𝐦𝐬𝐭𝐚𝐧𝐜𝐞𝐬 𝐏𝐨𝐬𝐭 𝟏/𝟑 - 𝐓𝐡𝐞 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞 𝗬𝗼𝘂𝗿 𝗹𝗼𝗻𝗴-𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝘀𝘂𝗯𝗰𝗼𝗻𝘁𝗿𝗮𝗰𝘁𝗼𝗿 𝗶𝘀 𝘀𝗵𝘂𝘁𝘁𝗶𝗻𝗴 𝗱𝗼𝘄𝗻. 𝗧𝗵𝗲 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗶𝘀 𝗮 𝘃𝗶𝘁𝗮𝗹 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲. 𝗬𝗼𝘂 𝗵𝗮𝘃𝗲 𝟭𝟴 𝗺𝗼𝗻𝘁𝗵𝘀 𝗮𝗻𝗱 𝗮𝗹𝗺𝗼𝘀𝘁 𝗻𝗼 𝗱𝗼𝗰𝘂𝗺𝗲𝗻𝘁𝗲𝗱 𝗽𝗿𝗼𝗰𝗲𝘀𝘀 𝗸𝗻𝗼𝘄𝗹𝗲𝗱𝗴𝗲. 𝗪𝗵𝗮𝘁 𝗱𝗼 𝘆𝗼𝘂 𝗱𝗼? This was the exact situation one of our clients faced with a Medicine of Importance to the Territory (MITM):  - A major risk of market disruption from the subcontractor's cessation of -operations   - An 18-month deadline to transfer and revalidate production — regulatory lead times included  - Total loss of product and process knowledge, held solely by the former manufacturer   - A highly sensitive aseptic product, vulnerable to cold, light, and oxygen No margin for error. No room for delay. And a patient population depending on the outcome. This is the kind of challenge Delpharm was built to handle. Next: how we rebuilt the process from the ground up. [Follow for part 2] 📄 We've written up the full technical case study   https://lnkd.in/eA9_WNjH  #SupplyContinuity #CDMO #IndustrialTransfer #Delpharm

    • Aucune description alternative pour cette image
  • Voir la Page de l’organisation de Delpharm

    73 207  abonnés

    𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐢𝐬 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐧𝐠 𝐚𝐭 𝐂𝐨𝐧𝐭𝐫𝐚𝐜𝐭 𝐏𝐡𝐚𝐫𝐦𝐚 𝟐𝟎𝟐𝟔! Join us in New Brunswick and meet Alain Huneault and Cedrick Billequey to discuss your pharmaceutical outsourcing needs and discover how Delpharm can support your projects across the drug development and manufacturing value chain. 📅September 24–25, 2026 📍 Hyatt Regency, New Brunswick, NJ, USA Table #115 Contract Pharma is a great opportunity to connect, exchange ideas, and explore new partnership opportunities with industry professionals from across the pharmaceutical sector. We look forward to meeting you in New Brunswick! #Delpharm #ContractPharma

    • Aucune description alternative pour cette image
  • Voir la Page de l’organisation de Delpharm

    73 207  abonnés

    𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐢𝐬 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐧𝐠 𝐚𝐭 𝐂𝐏𝐇𝐈 𝐌𝐢𝐥𝐚𝐧 𝟐𝟎𝟐𝟔! Join us in Milan to discover how we can support you at every stage of your product lifecycle, from development to commercial manufacturing, delivering high-quality solutions with reliability and flexibility. 🗓️ October 6-8, 2026 📍 Fiera Milano, Italy 📌 Stand 6H12 Let’s connect and explore new opportunities together! #CPHIMilan #CPHIWorldwide #PharmaInnovation #Delpharm

Pages affiliées

Pages similaires

Parcourir les offres d’emploi